Attached files

file filename
8-K - FORM 8-K - PETMED EXPRESS INCpets_8k.htm

Exhibit 99.1

PETMED EXPRESS D/B/A 1-800-PETMEDS

ANNOUNCES THIRD QUARTER FINANCIAL RESULTS

Earnings Increase 18% to $0.25 EPS

Net Sales Increase 11% to $48.4 million

Reorder Sales Increase 17% to $37.6 Million


Pompano Beach, Florida, January 19, 2010 - PetMed Express, Inc. (NASDAQ: PETS) today announced its financial results for the quarter ended December 31, 2009.  Net income was $5.6 million or $0.25 diluted per share for the quarter ended December 31, 2009, compared to net income of $4.9 million or $0.21 diluted per share for the quarter ended December 31, 2008, an 18% increase to EPS.  For the nine months ended December 31, 2009, net income was $19.9 million or $0.88 diluted per share, compared to net income of $17.3 million or $0.73 diluted per share for the nine months ended December 31, 2008, an increase to earnings per share of 20%.  Net sales for the quarter ended December 31, 2009 were $48.4 million, compared to $43.4 million for the quarter ended December 31, 2008, an increase of 11%.  Net sales for the nine months ended December 31, 2009 were $188.0 million, compared to $171.3 million for the nine months ended December 31, 2008, an increase of 10%.  Reorder sales increased by 17%, from $32.2 million to $37.6 million for the quarters ended December 31, 2008 and 2009, respectively.  Reorder sales for the nine months ended December 31, 2009 were $137.4 million, compared to $119.6 million for the nine months ended December 31, 2008, an increase of 15%.  


Menderes Akdag, President and CEO, commented: “We are pleased to report that our internet sales increased by 18% to $33.6 million for the quarter, compared to $28.6 million for the same quarter the prior year, with approximately 70% of our orders being generated from our website during the quarter, compared to 66% in the prior year.  During the quarter, the Company leveraged its operating expenses as a percent of sales, by 170 basis points as compared to the same quarter in the prior year.  We acquired approximately 151,000 new customers in the December quarter.  We are also pleased to report that our cash flows from operations increased to $28.9 million for the nine months ended December 31, 2009 from $15.8 million for the same period the prior year.  Going forward, our continuing focus will be on capturing additional market share, increasing reorders with personalized communication and health education content, and improving our customer service levels in fiscal 2010.”


This morning at 8:30 A.M. Eastern Time, Mr. Akdag will host a conference call to review the quarter’s financial results.  To access the call, which is open to the public, please dial (888) 455-1758 (toll free) or (210) 234-0009.  Callers will be required to supply PETMEDS as the passcode.  For those unable to participate in the live event, the call will be available for replay from 10:00 A.M. on January 19, 2010 until February 2, 2010 at 11:59 P.M.  To access the replay, call (866) 511-5160 (toll free) or (203) 369-1959, and enter passcode 5500.


Founded in 1996, PetMed Express is America’s Largest Pet Pharmacy, delivering prescription and non-prescription pet medications and other health products for dogs, cats, and horses at competitive prices direct to the consumer through its 1-800-PetMeds toll free number and on the Internet through its website at www.1800petmeds.com.


This press release may contain “forward-looking” statements, as defined in the Private Securities Litigation Reform Act of 1995 or by the Securities and Exchange Commission, that involve a number of risks and uncertainties, including the Company’s ability to meet the objectives included in its business plan.  Important factors that could cause results to differ materially from those indicated by such “forward-looking” statements are set forth in Management’s Discussion and Analysis of Financial Condition and Results of Operations in the PetMed Express Annual Report on Form 10-K for the year ended March 31, 2009.  The Company’s future results may also be impacted by other risk factors listed from time to time in its SEC filings, including, but not limited to, the Company's Form 10-Q and its Annual Report on Form 10-K.  For investment relations contact PetMed Express, Inc., Bruce S. Rosenbloom, CFO, 954-979-5995.




Exhibit 99.1 Page 1 of 4




PETMED EXPRESS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS


 

 

December 31,

 

March 31,

 

 

2009

 

2009

 

 

(UNAUDITED)

 

 

ASSETS

 

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

   Cash and cash equivalents

$

56,601,631 

$

30,126,041 

   Accounts receivable, less allowance for doubtful

 

 

 

 

      accounts of $24,066 and $58,525, respectively

 

1,181,931 

 

2,881,085 

   Inventories - finished goods

 

19,025,264 

 

26,778,096 

   Prepaid expenses and other current assets

 

784,653 

 

753,602 

   Deferred tax assets

 

1,150,445 

 

724,561 

   Prepaid income taxes

 

1,801,818 

 

361,743 

          Total current assets

 

80,545,742 

 

61,625,128 

 

 

 

 

 

   Long term investments

 

12,312,500 

 

14,430,250 

   Property and equipment, net

 

4,644,969 

 

5,057,561 

   Intangible assets

 

850,000 

 

850,000 

 

 

 

 

 

Total assets

$

98,353,211 

$

81,962,939 

 

 

 

 

 

LIABILITIES AND SHAREHOLDERS' EQUITY

 

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

   Accounts payable

$

3,477,508 

$

4,817,097 

   Accrued expenses and other current liabilities

 

2,010,330 

 

2,177,838 

          Total current liabilities

 

5,487,838 

 

6,994,935 

 

 

 

 

 

   Deferred tax liabilities

 

544,016 

 

 

 

 

 

 

Total liabilities

 

6,031,854 

 

6,994,935 

 

 

 

 

 

Commitments and contingencies

 

 

 

 

 

 

 

 

 

Shareholders' equity:

 

 

 

 

   Preferred stock, $.001 par value, 5,000,000 shares authorized;

 

 

 

 

      2,500 convertible shares issued and outstanding with a

 

 

 

 

      liquidation preference of $4 per share

 

8,898 

 

8,898 

   Common stock, $.001 par value, 40,000,000 shares authorized;

 

 

 

 

      22,846,686 and 22,686,836 shares issued and outstanding, respectively

22,847 

 

22,687 

   Additional paid-in capital

 

1,957,983 

 

   Retained earnings

 

90,519,129 

 

75,156,169 

   Accumulated other comprehensive loss

 

(187,500)

 

(219,750)

 

 

 

 

 

          Total shareholders' equity

 

92,321,357 

 

74,968,004 

 

 

 

 

 

Total liabilities and shareholders' equity

$

98,353,211 

$

81,962,939 




Exhibit 99.1 Page 2 of 4




PETMED EXPRESS, INC. AND SUBSIDIARIES

 CONDENSED CONSOLIDATED STATEMENTS OF INCOME

 (UNAUDITED)


 

 

 Three Months Ended

 

 Nine Months Ended

 

 

 December 31,

 

 December 31,

 

 

 2009

 

 2008

 

 2009

 

 2008

 

 

 

 

 

 

 

 

 

 Sales

$

48,353,607 

$

43,405,846 

$

187,969,366 

$

171,341,670 

 Cost of sales

 

29,525,562 

 

26,088,572 

 

116,172,990 

 

105,375,803 

 

 

 

 

 

 

 

 

 

 Gross profit

 

18,828,045 

 

17,317,274 

 

71,796,376 

 

65,965,867 

 

 

 

 

 

 

 

 

 

 Operating expenses:

 

 

 

 

 

 

 

 

      General and administrative

 

4,929,385 

 

5,019,183 

 

17,199,443 

 

16,448,431 

      Advertising

 

5,176,965 

 

4,899,893 

 

22,800,595 

 

23,619,602 

      Depreciation and amortization

 

336,834 

 

185,649 

 

981,647 

 

503,277 

 Total operating expenses

 

10,443,184 

 

10,104,725 

 

40,981,685 

 

40,571,310 

 

 

 

 

 

 

 

 

 

 Income from operations

 

8,384,861 

 

7,212,549 

 

30,814,691 

 

25,394,557 

 

 

 

 

 

 

 

 

 

 Other income:

 

 

 

 

 

 

 

 

      Interest income, net

 

46,091 

 

297,017 

 

164,678 

 

958,735 

      Other, net

 

1,162 

 

(27,616)

 

3,829 

 

301,835 

 Total other income

 

47,253 

 

269,401 

 

168,507 

 

1,260,570 

 

 

 

 

 

 

 

 

 

 Income before provision for income taxes

 

8,432,114 

 

7,481,950 

 

30,983,198 

 

26,655,127 

 

 

 

 

 

 

 

 

 

 Provision for income taxes

 

2,841,964 

 

2,597,182 

 

11,053,267 

 

9,328,053 

 

 

 

 

 

 

 

 

 

 Net income

$

5,590,150 

$

4,884,768 

$

19,929,931 

$

17,327,074 

 

 

 

 

 

 

 

 

 

 Net income per common share:

 

 

 

 

 

 

 

 

       Basic

$

0.25 

$

0.21 

$

0.88 

$

0.74 

       Diluted

$

0.25 

$

0.21 

$

0.88 

$

0.73 

 

 

 

 

 

 

 

 

 

 Weighted average number of common shares outstanding:

 

 

 

 

 

 

       Basic

 

22,649,491 

 

23,333,025 

 

22,596,204 

 

23,446,990 

       Diluted

 

22,789,731 

 

23,542,120 

 

22,742,196 

 

23,627,969 

 

 

 

 

 

 

 

 

 

 Cash dividends declared per common share

$

0.10 

 $

$

0.20 

 $




Exhibit 99.1 Page 3 of 4



PETMED EXPRESS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)

 

 

 Nine Months Ended

 

 

 December 31,

 

 

2009

 

2008

 Cash flows from operating activities:

 

 

 

 

    Net income

$

19,929,931 

$

17,327,074 

    Adjustments to reconcile net income to net cash

 

 

 

 

     provided by operating activities:

 

 

 

 

        Depreciation and amortization

 

981,647 

 

503,277 

        Share based compensation

 

1,158,015 

 

1,089,889 

        Deferred income taxes

 

118,132 

 

313,094 

        Bad debt expense

 

28,928 

 

48,656 

        (Increase) decrease in operating assets

 

 

 

 

           and increase (decrease) in liabilities:

 

 

 

 

             Accounts receivable

 

1,670,226 

 

(549,255)

             Inventories - finished goods

 

7,752,832 

 

(1,745,221)

             Prepaid income taxes

 

(1,440,075)

 

(4,000,000)

             Prepaid expenses and other current assets

 

(31,051)

 

30,283 

             Accounts payable

 

(1,055,672)

 

119,499 

             Income taxes payable

 

 

2,500,771 

             Accrued expenses and other current liabilities

 

(205,446)

 

146,009 

 Net cash provided by operating activities

 

28,907,467 

 

15,784,076 

 

 

 

 

 

 Cash flows from investing activities:

 

 

 

 

    Net change in investments

 

2,150,000 

 

(1,620,000)

    Purchases of property and equipment

 

(852,972)

 

(1,747,889)

    Purchase of intangible asset

 

 

(485,000)

 Net cash provided by (used in) investing activities

 

1,297,028 

 

(3,852,889)

 

 

 

 

 

 Cash flows from financing activities:

 

 

 

 

    Dividends paid

 

(4,529,033)

 

    Purchases of treasury stock

 

 

(6,776,696)

    Proceeds from the exercise of stock options

 

573,918 

 

1,535,035 

    Tax benefit related to stock options exercised

 

226,210 

 

233,188 

 Net cash used in financing activities

 

(3,728,905)

 

(5,008,473)

 

 

 

 

 

 Net increase in cash and cash equivalents

 

26,475,590 

 

6,922,714 

 Cash and cash equivalents, at beginning of period

 

30,126,041 

 

20,267,829 

 

 

 

 

 

 Cash and cash equivalents, at end of period

$

56,601,631 

$

27,190,543 

 

 

 

 

 

 Supplemental disclosure of cash flow information:

 

 

 

 

 

 

 

 

 

    Cash paid for income taxes

$

12,149,000 

$

10,281,000 

 

 

 

 

 

    Retirement of treasury stock

$

$

6,810,973 

 

 

 

 

 

    Property and equipment purchases in accounts payable

$

487,842 

$

1,801,026 

 

 

 

 

 

    Dividends payable in accrued expenses

$

37,938 

$




Exhibit 99.1 Page 4 of 4